2m 2m 2m 2m 2m 2m 2m
PHIO PHARMA (PHIO)
NASDAQ
$0.88+$0.005 (+0.63%)
Price as of Oct 22, 2026 7:30 PM EDT- $10.4MMarket Cap
- -57.59%1-Year Change
- BiotechnologyIndustry
PHIO PHARMA (PHIO)
$0.88+$0.005 (+0.63%)
PHIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.87 | ||
Change | +$0.003 (+0.31%) | ||
Open | $0.90 | ||
High | $0.91 | ||
Low | $0.87 | ||
Previous Close | $0.89 | ||
Volume | 53,623 | ||
30-Day Average Volume | 101,526 | ||
1-Week Change | -5.76% | ||
1-Month Change | -11.40% | ||
1-Year Change | -57.59% | ||
3-Year Change | -92.85% | ||
5-Year Change | -99.52% | ||
Fundamentals | |||
Shares Outstanding | 11.6M | ||
Total Assets | $14.3M | ||
Market Cap | $10.4M | ||
Enterprise Value | -$2.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.1M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$4.1M | ||
EBITDA | -$4.1M | ||
Net Working Capital | $12.6M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 07/05/2024 | ||
Earnings & Revenue